scPharmaceuticals Inc.

NASDAQ: SCPH · Real-Time Price · USD
4.11
-0.01 (-0.24%)
At close: Jun 05, 2025, 3:59 PM
4.00
-2.68%
After-hours: Jun 05, 2025, 06:55 PM EDT
-0.24%
Bid 3.65
Market Cap 216.98M
Revenue (ttm) 41.98M
Net Income (ttm) -90.78M
EPS (ttm) -1.92
PE Ratio (ttm) -2.14
Forward PE -14.33
Analyst Buy
Ask 4.36
Volume 595,219
Avg. Volume (20D) 478,441
Open 4.10
Previous Close 4.12
Day's Range 4.08 - 4.29
52-Week Range 1.94 - 5.65
Beta 0.36

About SCPH

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SCPH
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for SCPH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
3 weeks ago
+28.57%
scPharmaceuticals shares are trading higher after ... Unlock content with Pro Subscription
3 months ago
-1.89%
scPharmaceuticals shares are trading higher after the company announced FDA approval for a supplemental new drug application expanding the FUROSCIX indication to include the treatment of edema in patients with chronic kidney disease.